Patent intelligence · US
US 6670148
Compositions comprising bioactive peptides prepared without formation of native disulfide bonds
Compositions comprising bioactive peptides prepared without formation of native disulfide bonds
Patent details — US 6670148
- Jurisdiction
- US
- Status
- expired
- Grant date
- Dec 30, 2003
- Expiration
- Dec 25, 2023
- Applicant
- Biotherapeutics, Inc.
- Claims
- 9
- CPC classes
- A61P, A61P37/00
Quick answer
US 6670148 (Compositions comprising bioactive peptides prepared without formation of native disulfide bonds) is held by Biotherapeutics, Inc.. Status: expired. Granted Dec 30, 2003. Expires Dec 25, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Biotherapeutics, Inc.
- Grant date
- Expiration
- Claims
- 9
- CPC classes
- A61P, A61P37/00
More from Biotherapeutics, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12343380
Expansion of TILs utilizing AKT pathways inhibitors
granted -
US 12280140
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
granted -
US 12233075
Remnant tumor infiltrating lymphocytes and methods of preparing and using the same
granted -
US 12230378
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12226434
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12230379
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12194061
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12188048
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted
Frequently asked questions
What is US patent 6670148?
US 6670148 (Compositions comprising bioactive peptides prepared without formation of native disulfide bonds) is held by Biotherapeutics, Inc.. Status: expired. Granted Dec 30, 2003. Expires Dec 25, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6670148?
Biotherapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 94 pharmaceutical patents for this assignee.
When does US 6670148 expire?
Our index shows an expiration date of Dec 25, 2023 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.